Thu, Sep 18, 2014, 1:19 AM EDT - U.S. Markets open in 8 hrs 11 mins

Recent

% | $
Quotes you view appear here for quick access.

PHAZAR CORP Message Board

hugeman99 12 posts  |  Last Activity: Sep 5, 2014 7:28 AM Member since: Jan 21, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Hey emotion boy, you're still carrying that 200,000lb ($200K) chip on your shoulder, aren't you?

    How'd all them expensive put options work out that you bought ahead of PhII data? Pretty much worthless at this point, eh?

    Remember back in February how YOU ran Phakosurgeon off the board when he was he skeptical of squal??? That was back when you had your cranium firmly inserted in L10's sphinctor as the stock was rising.

    It really bothers you that I layed my cards on the table, played the trade without emotion and made money, doesn't it?

    To quote Don Henley of the Eagles..... 'you keep carrying that anger, it will eat you up inside'

    Maybe you and Richmando can car pool to anger management classes.

  • With the millions tha Almenoff pocketed selling Furiex Pharma, why is she wasting time on penny ante purchases. Tell me it's not a facade.

  • Reply to

    Management is way too passive in getting the story out

    by ps7835 Aug 19, 2014 10:30 AM
    hugeman99 hugeman99 Sep 1, 2014 11:43 AM Flag

    How about just running and growing the business? Investor relastions campaigns takes up managements time and cost money.

    That #$%$ just moves the stock price in the short term, so unless the company is needs to sell shares to grow, it's actually a disservice to shareholders who are in for the long term.

    I say we let Mr. Ulland keep doing what he's doing. But I will say one thing, at 73 years old, maybe it's time to get someone younger running the company day to day and let him run the board.

  • hugeman99 hugeman99 Aug 24, 2014 8:47 PM Flag

    Hey planet_Fukknutts. You really have some self esteem issues, don't you?

    Just took a look at your last dozen or so posts. Pretty much nothing useful in any of them and full of criticism of anything anyone else has to say.

    I've been on this earth long enough to know that people who make posts like yours are unhappy with themselves and bully others to make themselves feel better. I pity anyone who has to interact with you on a day to day basis.

    Over the weekend I saw a rerun of the movie 'The Breakfast Club', John Bender, that pretty much sums you up.

    p.s. Your first posts in three months, you been in rehab or county jail? Only a dozen posts in the last two years, having trouble paying for your dial up?

  • Cut in half on the offering. OUCH.

    That said, I like what I see here now. I grabbed some shares this morning sub $5.

    With some working capital they can hire sales staff and build inventory for growth. Looking forward to next investor call to ask a few questions.....

    Sentiment: Buy

  • hugeman99 hugeman99 Jul 29, 2014 7:20 PM Flag

    Which Opti are you talking about, the complete jerk who insulted and drove skeptics off the board with regularity on the way up, or the jaded and bitter one who insulted anyone who had a shred of optimism ahead of the data?

    They both took a bath in this stock.

  • hugeman99 hugeman99 Jul 29, 2014 7:08 PM Flag

    Hey Richmando.....

    Blow it out your #$%$! What's your problem, you take a m#$%$ive loss on OHRP like that other clown Optimist_77?

    Don't #$%$ociate me with Livermore_10 or anybody else. I was never a lemming of his, but if my memory serves me well, you drank your share of his Kool-Aid. I met him at the shareholder meeting, he was real AND he was a fallible human.

    Before the pain of your financial loss causes you to make any more inaccurate accusations about me, YOU SHOULD READ ALL OF MY POSTS on OHRP board, you'll need to go back to the middle of 2013.

    After that, if for some emotional reason you want to engage in a tit-for-tat argument, have at it.

    Tell me where my credibility is in question, site my specific posts and I'll defend myself.

    Until you do that, you are just another guy who made bad trading decisions and wants to blame it on somebody else, just like Optimist_77.

    Livermore_10's cost basis on his 80K+ shares of OHRP was somewhere around $2.70 post reverse-split, #$%$uming from his month plus absence on his private board that he has liquidated, he had a triple, and a $400K profit. My profit's were only a fraction of that, but they DEFINITELY were nice profits. I never told anyone to buy this stock.

    Who lost more money on OHRP, You or Optimist_77? Or are you still setting on a big money losing position hoping for that one day pop that lets you exit with a little bit less of a loss?

    When it comes to trading/investing, hope is NOT a viable strategy.

    Nobody forced you to press the 'Buy' button, #$%$, NOBODY!

    p.s. I'm not a StuartCreekFarms lemming either. But if anybody on this board was credible, it was him. Knowledgeable, level headed and well reasoned.

  • Hey Stuart, AAVL IPO coming this week, any thoughts?

    Gene therapy for eye diseases.

    Adage Capital who were PBYI investors are AAVL investors too.

  • Reply to

    was the p-value really .18 like adam says

    by charles_lacy2003 Jun 24, 2014 1:41 PM
    hugeman99 hugeman99 Jun 24, 2014 2:12 PM Flag

    charles, now you are stuck in that dog LPTN and OHRP (remember, you told us you were long OHRP as a hedge).

    Maybe Pancoast will take you in a ride in his Lamborgini after the LPTN shareholder meeting this week. After all, you and the other LPTN shareholders bought it for him. Zoom, zoom!

    Still waiting to see who buys that iSONEP option from PFE, when was that supposed to happen, April? Can you ask Pancoast about that for me? Thanks!

  • Reply to

    Dr. Slakter was very good on CC

    by stuartcreekfarms Jun 24, 2014 9:25 AM
    hugeman99 hugeman99 Jun 24, 2014 12:19 PM Flag

    Correct me if I'm wrong, there was no statistical significance to the visual acuity differences? How often do we actually see statistical significance even in PhII small sample that disappears when we have 300+ patients as will be required in PhIII? And since squalamine didn't decrease lesion size as the calmodulin binding theory suggested, we don't really know what it's doing in there, do we? Help me understand, how do we get visual acuity improvements without reducing lesion size? Couldn't the acuity difference seen thus far end up being just a statistical anomoly? As a lay person I have no way of putting into perspective how significant an improvement of 10.4 letters vs 6.3 letters is or how credible the idea of improved visual acuity without reducing lesion size is.

    On the conference call, Slakter even had to beg off on how/why squalamine improved visual acuity since it didn't reduce injections, the primary endpoint. To quote Slakter 'It APPEARS squalamine is exerting it's effect in a more basic level, at the pathophysiology of the disease, at the neovascular tissue, at fibrosis and inflamation that MIGHT be associated with it.' I'd feel a lot better about squalamine if Slakter said WE KNOW that squalmine is improving visual acuity because it...... ('It appears' and 'might' don't give me a lot of confidence we know just what is going on).

    Also on the call Slakter made it clear there is no provision or plan to tweek the retreatment criteria in the current trial and no plan to start a PhIII trial until PhII is complete. Thus any trial with more favorable retreatment criteria is going to need to go through the entire FDA process. That's going to take another two years.

    Maybe a big pharma will be willing to throw some seed money at OHRP to keep them going, but for now we have significant cash burn from the current trial AS WELL AS FUNDING SKS and it's early stage trials before we ever see if the visual improvements are actually real.

  • hugeman99 hugeman99 Jun 24, 2014 12:14 PM Flag

    In case I wasn't clear, Adam story just hit thestreetdotcom

ANTP
1.250.00(0.00%)Jul 31 1:39 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.